Logo image of CPZ

CALAMOS LNG/SHRT EQTY & DYN (CPZ) Stock Fundamental Analysis

NASDAQ:CPZ - Nasdaq - US12812C1062 - Currency: USD

15.73  0 (0%)

Fundamental Rating

1

Taking everything into account, CPZ scores 1 out of 10 in our fundamental rating. CPZ was compared to 0 industry peers in the Unkown industry. CPZ has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CPZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CPZ was profitable.
In the past year CPZ has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CPZ reported negative net income in multiple years.
In multiple years CPZ reported negative operating cash flow during the last 5 years.
CPZ Yearly Net Income VS EBIT VS OCF VS FCFCPZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA -2.18%
ROE -3.82%
ROIC N/A
ROA(3y)3.33%
ROA(5y)N/A
ROE(3y)5.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CPZ Yearly ROA, ROE, ROICCPZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

In the last couple of years the Operating Margin of CPZ has grown nicely.
CPZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y4.76%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CPZ Yearly Profit, Operating, Gross MarginsCPZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 100 -100 200 300

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for CPZ remains at a similar level compared to 1 year ago.
Compared to 1 year ago, CPZ has a worse debt to assets ratio.
CPZ Yearly Shares OutstandingCPZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
CPZ Yearly Total Debt VS Total AssetsCPZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that CPZ is in the distress zone and has some risk of bankruptcy.
CPZ has a Debt/Equity ratio of 0.62. This is a neutral value indicating CPZ is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACCN/A
CPZ Yearly LT Debt VS Equity VS FCFCPZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.63 indicates that CPZ may have some problems paying its short term obligations.
CPZ has a Quick Ratio of 0.63. This is a bad value and indicates that CPZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.63
CPZ Yearly Current Assets VS Current LiabilitesCPZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

CPZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 125.62%, which is quite impressive.
The Revenue has grown by 465.82% in the past year. This is a very strong growth!
Measured over the past years, CPZ shows a very strong growth in Revenue. The Revenue has been growing by 41.76% on average per year.
EPS 1Y (TTM)125.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.98%
Revenue 1Y (TTM)465.82%
Revenue growth 3Y41.76%
Revenue growth 5YN/A
Sales Q2Q%127.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPZ Yearly Revenue VS EstimatesCPZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 0 20M 40M 60M
CPZ Yearly EPS VS EstimatesCPZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.09, which means the current valuation is very expensive for CPZ.
CPZ is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.09
Fwd PE N/A
CPZ Price Earnings VS Forward Price EarningsCPZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPZ Per share dataCPZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CPZ has a Yearly Dividend Yield of 11.98%, which is a nice return.
CPZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 11.98%

5.2 History

CPZ has been paying a dividend for over 5 years, so it has already some track record.
CPZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
CPZ Yearly Dividends per shareCPZ Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

The earnings of CPZ are negative and hence is the payout ratio. CPZ will probably not be able to sustain this dividend level.
DP-247.38%
EPS Next 2YN/A
EPS Next 3YN/A
CPZ Yearly Income VS Free CF VS DividendCPZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 100M -100M -200M -300M

More info and screens

CALAMOS LNG/SHRT EQTY & DYN

NASDAQ:CPZ (2/4/2025, 8:00:00 PM)

15.73

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners40.32%
Inst Owner Change0.26%
Ins Owners0.81%
Ins Owner Change-625.27%
Market Cap308.78M
Analysts0
Price TargetN/A
Short Float %0.25%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 11.98%
Yearly Dividend1.68
Dividend Growth(5Y)N/A
DP-247.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.09
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)0.56
EY3.56%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.29
FCFYN/A
OCF(TTM)-3.29
OCFYN/A
SpS-0.88
BVpS17.77
TBVpS17.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.18%
ROE -3.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.33%
ROA(5y)N/A
ROE(3y)5.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y4.76%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.03
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.63
Altman-Z 0.3
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)465.82%
Revenue growth 3Y41.76%
Revenue growth 5YN/A
Sales Q2Q%127.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-175.25%
EBIT growth 3Y48.51%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1062.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1062.69%
OCF growth 3YN/A
OCF growth 5YN/A